In the last 20 years, the interest in the treatment of conditions such as cancer, depression, sleep, and neurological disorders by cannabis and cannabinoids has been growing in patients and scientists. Some EU countries, therefore, approve or intend to permit some form of medicinal cannabis or cannabinoid use. 

However, there is broad variance in terms of authorization of products and how their supply is regulated by the regulatory frameworks. Small amounts of recreational cannabis have also been decriminalized, but selling and cultivation are not allowed. Efforts to prohibit recreational cannabis have failed in Europe, but access for medical purposes remains difficult. 

A stronger solution is to legalize the cultivation, selling, and use of cannabis under a system of public monopoly so that its use can be regulated. To guarantee the reliability of customers and sales, the state must place the price higher than it does today. This will also increase considerable tax revenues and slash public expenditure on law enforcement. 

Probably many cannabis experiments, including in Luxembourg. are already underway. Nonetheless, a broader solution will further benefit users by maintaining plant safety standards. It also will provide the patients with stronger guarantees, improved drug awareness for physicians, and more research investment. cannabis legalization in Europe will also provide agricultural economic opportunities. 

Consider legalizing weed for recreational use 

The discussion on the legalization of recreational marijuana is split, but the much-needed legal changes surrounding the medicinal and industrial use of cannabis should be retained. 

Governments continue to disagree as people continue to be divided. Around this incredibly flexible plant, there is a heavy cultural stigma. For example, cannabis could only be used to produce drugs, food, textiles, bioplastics, bioplastics, biofuels, cosmetics, and green buildings. Land regeneration for the environment is also a significant value of cannabis. Also, “medical cannabis” does not only apply to EU-authorized products extracted from cannabis, but also to cannabis preparations like raw cannabis, plant oil, extracts of cannabis, and others. 

We should discuss the recreational use by adults of cannabis because regulating the entire chain from cultivation to purchase will benefit society, ensuring that healthy products are sold on the market. Legalization will lead to phasing out black markets and transfer profits from organized crime to public services, with the correct legal structure and effective compliance structures. However, data from the history of European Union countries that have already legalized recreational marijuana should be collected and evaluated to assess the benefits and drawbacks of such a change in policies. 

Prioritize access to cannabis 

Total legalization is the most effective way to regulate cannabis. As long as we are separating medicinal and leisure use, we have more trouble in providing convenient access for people who use cannabis for medicinal practice. What is the reason? Since the medical profession uses other principles to work by, they need to conduct comprehensive work to identify different conditions for which cannabis can be prescribed. They will decide on the requirements to be administered. These factors are taken together and do not include patients. 

In an exceptionally wide range of situations, cannabis is beneficial. This has proved to be a safe and effective method in the recovery cycle across centuries of experience. Ultimately it is better left to the doctors and patients to determine how to use cannabis. We cut off a large percentage of patients by unnecessarily taxation and leave them at the whim of the illegal market. 

This trap can only be avoided through full cannabis legalization in Europe. We can only govern entirely through legalization. There is a very good example in Canada. They have legalized and controlled, and are now enjoying the advantage of their decision. 

The EU should provide member states with information by measures such as directives. It should do it right now, but it has still not taken the initiative with medical cannabis. Each Member State has, therefore, no idea what it will do concerning EU policy on the use of cannabis. Certainly, it cannot force a country to comply with an order. For any EU member to legalize cannabis, however, this would result in more immediate and homogenous legislative changes. 

Conclusion 

EU can provide the Member States with information using resources such as directives. This may be done with medicinal cannabis at present, but the project has not been pursued yet. Each Member State has, therefore, no idea what it will do in EU policy about the cannabis legalization in Europe for medicinal use. Brussels certainly cannot compel a country to comply with a directive. To legalize cannabis for every EU member, however, this will result in more rapid and effective legislative reforms across the EU. 

High quality marijuana :- buyweedonline